These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 10670410)
1. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Cuadrado MJ; Khamashta MA; Ballesteros A; Godfrey T; Simon MJ; Hughes GR Medicine (Baltimore); 2000 Jan; 79(1):57-68. PubMed ID: 10670410 [TBL] [Abstract][Full Text] [Related]
2. Hughes syndrome and multiple sclerosis. Uthman I; Noureldine MH; Berjawi A; Skaf M; Haydar AA; Merashli M; Hughes GR Lupus; 2015 Feb; 24(2):115-21. PubMed ID: 25326228 [TBL] [Abstract][Full Text] [Related]
3. Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies? Noureldine MH; Harifi G; Berjawi A; Haydar AA; Nader M; Elnawar R; Sweid A; Al Saleh J; Khamashta MA; Uthman I Lupus; 2016 Nov; 25(13):1397-1411. PubMed ID: 27225212 [TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Ferreira S; D'Cruz DP; Hughes GR Rheumatology (Oxford); 2005 Apr; 44(4):434-42. PubMed ID: 15644391 [TBL] [Abstract][Full Text] [Related]
5. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? IJdo JW; Conti-Kelly AM; Greco P; Abedi M; Amos M; Provenzale JM; Greco TP Lupus; 1999; 8(2):109-15. PubMed ID: 10192504 [TBL] [Abstract][Full Text] [Related]
6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus. İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535 [TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients. Ma J; Song H; Wei M; He Y Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509 [TBL] [Abstract][Full Text] [Related]
10. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. Marai I; Levi Y; Godard G; Shoenfeld Y Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848 [TBL] [Abstract][Full Text] [Related]
11. Combined brain/heart magnetic resonance imaging in antiphospholipid syndrome-two sides of the same coin. Markousis-Mavrogenis G; Sfikakis PP; Mavrogeni SI; Tektonidou MG Clin Rheumatol; 2021 Jul; 40(7):2559-2568. PubMed ID: 33196982 [TBL] [Abstract][Full Text] [Related]
12. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study. Chen J; Sun S; Yan Q; Bao C; Fu Q Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544 [TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study. Ricard L; Laurent C; Papo M; Deriaz S; Catano J; Alamowitch S; Kayem G; Chasset F; De Moreuil C; Boffa JJ; Gerotziafas G; Elalamy I; Bornes M; Maillot F; Audemard-Verger A; Planche V; Ballot E; Fain O; Mekinian A Joint Bone Spine; 2022 Mar; 89(2):105297. PubMed ID: 34656751 [TBL] [Abstract][Full Text] [Related]
15. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems]. Zdrojewski Z Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350 [TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
17. Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus. Lampropoulos CE; Koutroumanidis M; Reynolds PP; Manidakis I; Hughes GR; D'Cruz DP Arthritis Rheum; 2005 Mar; 52(3):841-6. PubMed ID: 15751063 [TBL] [Abstract][Full Text] [Related]
18. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome. Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279 [TBL] [Abstract][Full Text] [Related]
19. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome. Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162 [TBL] [Abstract][Full Text] [Related]